Gameto is a biotechnology firm dedicated to understanding and treating infertility and menopause. The company deals with accelerated ovarian aging to change the trajectory of women's health and equality. It aims to leverage the allogeneic human cellular derivatives of their platform to therapeutic applications for assisted fertility and menopause.